Cargando…
Meta-analysis of the association of the haptoglobin genotype with cardiovascular outcomes and the pharmacogenomic interactions with vitamin E supplementation
OBJECTIVES: The objectives of the study were to compile and summarize the data from all of the clinical trials designed to examine the association between haptoglobin (Hp) genotype and incidence of cardiovascular (CV) events in patients with diabetes mellitus (DM) and to assess the impact of vitamin...
Autores principales: | Asleh, Rabea, Briasoulis, Alexandros, Berinstein, Elliot M, Wiener, Joshua B, Palla, Mohan, Kushwaha, Sudhir S, Levy, Andrew P |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Dove Medical Press
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5923226/ https://www.ncbi.nlm.nih.gov/pubmed/29731659 http://dx.doi.org/10.2147/PGPM.S159454 |
Ejemplares similares
-
Pharmacogenomic application of the haptoglobin genotype in the treatment of HDL dysfunction
por: Schwartz, Avery, et al.
Publicado: (2009) -
Post-transplant Lymphoproliferative Disorder Following Cardiac Transplantation
por: Asleh, Rabea, et al.
Publicado: (2022) -
In Vivo and In Vitro Studies Establishing Haptoglobin as a Major Susceptibility Gene for Diabetic Vascular Disease
por: Asleh, Rabea, et al.
Publicado: (2005) -
Correction of HDL Dysfunction in Individuals With Diabetes and the Haptoglobin 2-2 Genotype
por: Asleh, Rabea, et al.
Publicado: (2008) -
Outcomes after heart transplantation in patients with cardiac sarcoidosis
por: Asleh, Rabea, et al.
Publicado: (2022)